Tenet Healthcare Corporation
$ 175.32
1.22%
29 May - close price
- Market Cap 14,918,928,000 USD
- Current Price $ 175.32
- High / Low $ 179.56 / 171.13
- Stock P/E 9.42
- Book Value 48.53
- EPS 18.39
- Next Earning Report 2026-07-21
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.08 %
- ROE 0.30 %
- 52 Week High 247.21
- 52 Week Low 146.60
About
Tenet Healthcare Corporation is a diversified health services company. The company is headquartered in Dallas, Texas.
Analyst Target Price
$244.57
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-07-21 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 4.18 |
| Currency | USD |
Previous Dividend Records
| Jan 1970 | |
|---|---|
| Payment Date | None |
| Amount | $0.01 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: THC
2026-05-29 02:09:11
Nadja West, a Director at Tenet Healthcare Corp (THC), sold 3,000 shares of the company on May 27, 2026, reducing her holdings to 24,805 shares. This sale is part of a trend of 17 insider sells and no insider buys at Tenet Healthcare over the past year. The stock is currently trading at $177.35, which is considered fairly valued according to GuruFocus's GF Value.
2026-05-29 00:10:18
Tenet Healthcare director Roy Blunt was granted 1,188 restricted stock units (RSUs) as an equity award on May 27, 2026. These RSUs, which vest on May 27, 2027, are economically equivalent to common stock and serve as time-based compensation, aligning his interests with shareholders. Blunt has the option to receive up to 37% of the vested units in cash, while the remaining balance would convert to shares.
2026-05-29 00:09:11
Tenet Healthcare Corp (NYSE: THC) director Nadja West reported an open-market sale of 3,000 shares at $177.35 per share, reducing her direct holdings to 24,805 shares. Concurrently, she was granted 1,188 restricted stock units (RSUs) that vest on the first anniversary of the grant, with an option to receive up to 37% of these units in cash. The filing impact is deemed high with a negative sentiment, reflecting both a decrease in direct stock ownership and an award of future equity.
2026-05-29 00:09:11
Tenet Healthcare Corp director Vineeta Agarwala reported an acquisition of 1,188 restricted stock units (RSUs) on May 27, 2026, as detailed in a Form 4 SEC filing. These RSUs, granted at no cost, will vest on the first anniversary of the grant date and are economically equivalent to one share of common stock each. Agarwala now directly holds 1,188 RSUs, with an option to receive up to 37% of vested units in cash.
2026-05-29 00:09:11
Tammy Romo, a director at Tenet Healthcare (NYSE: THC), was granted 1,188 restricted stock units (RSUs) under the company’s Stock Incentive Plan on May 27, 2026. These RSUs, each equivalent to one common share, will vest on the first anniversary of the grant date. Romo has the option to elect up to 37% of these units in cash instead of shares.
2026-05-29 00:09:11
Tenet Healthcare (NYSE: THC) director James L. Bierman was awarded 1,188 restricted stock units (RSUs) on May 27, 2026, as reported in a Form 4 filing. These units, which vest on the first anniversary of the grant date, are the economic equivalent of 1,188 shares of common stock and were granted at no cost. Bierman has the option to elect to receive up to 37% of the vested units in cash, with the remainder settled in stock.
